Hypoalbuminaemia as a Prognostic Biomarker of First-Line Treatment Resistance in Metastatic Non-small Cell Lung Cancer

Introduction: Despite significant advances in systemic anticancer therapy (SACT) for non-small cell lung cancer (NSCLC), many patients still fail to respond to treatment or develop treatment resistance. Albumin, a biomarker of systemic inflammation and malnutrition, predicts survival in many cancers...

Descripción completa

Detalles Bibliográficos
Autores principales: Stares, Mark, Swan, Amanda, Cumming, Kirsten, Ding, Tze-En, Leach, James, Stratton, Cory, Thomson, Findlay, Barrie, Colin, MacLennan, Kirsty, Campbell, Sorcha, Evans, Tamasin, Tufail, Aisha, Harrow, Stephen, MacKean, Melanie, Phillips, Iain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517082/
https://www.ncbi.nlm.nih.gov/pubmed/34660664
http://dx.doi.org/10.3389/fnut.2021.734735

Ejemplares similares

Ejemplares similares